Phase 3 BMN 701 in rhGAA Exposed Subjects with Late-Onset Pompe Disease
Clinical Trial Grant
Administered By
School of Medicine
Awarded By
BioMarin Pharmaceutical, Inc.
Start Date
June 1, 2014
End Date
May 31, 2016
Administered By
School of Medicine
Awarded By
BioMarin Pharmaceutical, Inc.
Start Date
June 1, 2014
End Date
May 31, 2016